SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-004737
Filing Date
2023-01-18
Accepted
2023-01-18 20:10:19
Documents
2
Period of Report
2023-01-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm233829-9_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm233829-9_4seq1.xml 4 3986
2 EXHIBIT 24 tm233829d9_ex24.htm EX-24 5614
  Complete submission text file 0001104659-23-004737.txt   11203
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Williams Lewis T (Reporting) CIK: 0001475714 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 23535686